DHT-UN DRI Healthcare Trust

13.25USD18.95 CAD · TSX-0.79%Mkt Cap: 745.33M USDP/E: 12.63

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeu…

Insiders, last 90 days8 buys
Institutional holders1 on file

Key Statistics

Company
Market Cap745.33M USD
Enterprise Value1.12B USD
Revenue (TTM)200.52M USD
Gross Profit203.79M USD
Net Income (TTM)-50.47M USD
Revenue/Share3.64 USD
Last Price13.25 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees32
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)12.63
P/E (Forward)4.78
PEG—
EV/EBITDA9.34
EV/Revenue5.60
P/S5.32
P/B1.56
EPS (TTM)1.50 USD
EPS (Forward)3.97 USD
52W Range
10.4982% of range13.87
52W High13.87 USD
52W Low10.49 USD
Profitability
Gross Margin100.00%
Oper. Margin33.71%
EBITDA Margin85.72%
Profit Margin-32.91%
ROE-11.51%
ROA-5.35%
ROIC—
ROCE—
Growth
Revenue Growth-3.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF109.95M USD
CapEx (TTM)87.99M USD
FCF Margin-159.94%
FCF Yield-43.03%
Net Debt566.16M USD
Net Debt/EBITDA3.29
Net Debt/FCF—
Balance Sheet
Debt/Equity0.86
Current Ratio1.64
Quick Ratio1.32
Book Value/Sh12.13 USD
Cash/Share0.75 USD
Dividends
Fwd Div Rate0.44 USD
Trail. Div Rate0.30 USD
Div. Yield3.29%
5Y Avg Yield3.38%
Payout Ratio39.81%
Ex-Div DateDec 31, 2026
Pay DateOct 20, 2026
Splits
Last Split997:1000
Split DateDec 31, 2024
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)17.52 USD
Upside (mean)+32.3%
Target Range15.75 USD – 19.69 USD
15.75+32.3% to mean19.69
# Analysts8
Ownership
Shares Out.0
Float—
Insiders0.24%
Institutions52.84%
Short Interest
Short Ratio0.5d
Short % Out.0.03%
Shares Short18.26K
Short (prev mo.)13.70K
Technical
SMA 5012.78 (+3.7%)
SMA 20012.23 (+8.4%)
Beta0.54
S&P 52W Chg12.00%
Avg Vol (30d)31.15K
Avg Vol (10d)35.04K
Technical Indicators
RSI (14)53.7
MACD0.2712
MACD Signal0.2888
MACD Hist.-0.0175
BB Upper13.92 USD
BB Middle13.16 USD
BB Lower12.41 USD
BB Width11.43%
ATR (14)0.3216 USD
Vol Ratio (20d)0.83x

About DRI Healthcare Trust (TSE: DHT-UN)

›

DRI Healthcare Trust (TSE: DHT-UN) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 32 employees.

The shares were at 18.95 CAD on 19 November 2026, up 22.5% over 52 weeks. Its 52-week range is 15.00 CAD to 19.84 CAD: the price is 4.5% below the high and 26.3% above the low.

At a market capitalisation of 1.07B CAD, it trades at 12.6 times trailing earnings and 4.8 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 49% for DHT-UN. It pays a dividend yielding 3.29% (it pays out 40% of its earnings), against a median of 1.90% among the dividend payers in that peer group.

DRI Healthcare Trust reports return on equity of -11.5%, an operating margin of 33.7% and revenue down 3.8% year over year.

Its debt exceeds its cash by 566.16M USD, a debt-to-equity ratio of 0.86. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 8 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 25.06 CAD is 32.3% above the current price. The next earnings report is expected on 3 March 2027.